Pharma Research Products Co., Ltd Logo

Pharma Research Products Co., Ltd (214450)

KRX

Currency in KRW
414,500.00
-1,500.00 (-0.36%)

Closed

Aug 25, 2026

Day's Range

403,500.00
419,000.00

52 wk Range

255,000.00
713,000.00

Overview - 214450 - Pharma Research Products Co., Ltd

Key Statistics

Valuation

Enterprise Value

3.94T

P/E (Trailing)

‪26.08‬

P/E (Forward)

‪17.57‬

PEG Ratio

‪0.82‬

Price / Sales (TTM)

‪7.52‬

Price / Book

‪5.87‬

EV / EBITDA

‪16.32‬

Profitability

Gross Margin

‪77.29%‬

Profit Margin

‪31.21%‬

Operating Margin

‪39.40%‬

Return on Assets

‪14.25%‬

Return on Equity

‪27.25%‬

Ownership

Shares Outstanding

10.38M

Float

5.57M

Held by Insiders

‪34.96%‬

Held by Institutions

‪15.48%‬

Price stats

Beta

‪0.45‬

50-Day Avg

‪350,400.00‬

200-Day Avg

‪362,122.50‬

Dividends

Payout Ratio

‪21.20%‬

Frequency

Annual

Analyst Consensus

Buy

14 analysts

Average price target

‪₩ 508,357.16‬

Market Cap - 214450 - Pharma Research Products Co., Ltd

Peers - 214450 - Pharma Research Products Co., Ltd

Peer Comparison

Compared with companies in Biotechnology listed on KRX.

Profile Summary - 214450 - Pharma Research Products Co., Ltd

About

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN…

SectorHealthcare
IndustryBiotechnology
Employees541
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.